Detalhe da pesquisa
1.
Patients' and caregivers' maximum acceptable risk of death for non-curative gene therapy to treat Duchenne muscular dystrophy.
Mol Genet Genomic Med
; 9(5): e1664, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755338